Sigma Planning’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$777K Sell
15,100
-14,900
-50% -$756K 0.02% 670
2026
Q2
$1.09M Buy
+30,000
New +$880K 0.03% 568

Other funds holding ETON

Sigma Planning's ETON Position: Q3 2026 in Review

Sigma Planning reduced its Eton Pharmaceutcials (ETON) stake by 50% in Q3 2026, selling an estimated $756K and leaving 15,100 shares worth $777K. The position accounts for 0.02% of the portfolio, ranked #670.

Sigma Planning first reported a position in ETON in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.09M in Q2 2026. 162 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Sigma Planning held 15,100 shares of Eton Pharmaceutcials worth $777K as of Q3 2026.
  • Sigma Planning sold 14,900 Eton Pharmaceutcials shares in Q3 2026, an estimated $756K.
  • Eton Pharmaceutcials made up 0.02% of Sigma Planning's portfolio in Q3 2026, its #670 holding.
  • Sigma Planning first reported a position in Eton Pharmaceutcials in Q2 2026 and has held it in 2 quarters since.
  • Sigma Planning's Eton Pharmaceutcials position peaked at $1.09M in Q2 2026.
  • 162 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.